Author:
Colzi A.,Zürcher G.,Da Prada M.
Reference5 articles.
1. Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE (1984) The pharmacology of Parkinson’s disease: basic aspects and recent advances. Experientia 40: 1165–1172
2. Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE (1987) Inhibition of decarboxylase and levels of DOPA and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. Eur Neurol 27 [Suppl] 1: 9–20
3. Ito S, Kato T, Maruta K, Fujita K, Kurahashi T (1984) Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection. J Chromatogr 311: 154–159
4. Zürcher G, Da Prada M (1979) Radioenzymatic assay of femtomole concentrations of DOPA in tissues and body fluids. J Neurochem 33: 631–639
5. Zürcher G, Keller HH, Kettler R, Schaffner R, Bonetti EP, Borgulya J, Da Prada M (1988) DOPA-potentiating effects of Ro 41–0960: neuro-pharmacological profile of a novel reversible, orally active COMT inhibitor. Proceedings, 9th International Symposium on Parkinson’s disease, Jerusalem
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献